A double-blind, randomized, placebo-controlled trial of adjunctive ramelteon for the treatment of insomnia and mood stability in patients with euthymic bipolar disorder

Journal of Affective Disorders

Volumn 144, Issue 1-2, 2013, Pages 141-147

  Norris, Edward R ^a   Karen Burke, ^a   Correll, Julia R ^a   Zemanek, Kenneth J ^a   Lerman, Joel ^a   Primelo, Ralph A ^a   Kaufmann, Michael W ^a  

^a LEHIGH VALLEY HOSPITAL   (United States)

Author keywords

Bipolar disorder; Circadian rhythm; Euthymia; Melatonin; Ramelteon

Indexed keywords

PLACEBO; RAMELTEON;

ADULT; AGED; ANXIETY; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EUTHYMIC BIPOLAR DISORDER; FATIGUE; FEMALE; HEADACHE; HUMAN; INSOMNIA; KAPLAN MEIER METHOD; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MANIA; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SIDE EFFECT; SLEEP DISORDER; SLEEP QUALITY; SOMNOLENCE; SURVIVAL TIME; TREATMENT DURATION; VIVID DREAM;

ADULT; AFFECT; ANTIMANIC AGENTS; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INDENES; MALE; MIDDLE AGED; PLACEBOS; RECURRENCE; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

EID: 84870289248     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.06.023     Document Type: Article

References (31)

1. American Psychiatric Association (APA) Diagnostic and Statistical Manual of Mental Disorders 4th edition 2000 American Psychiatric Association Washington, DC Text Revision
2. D.J. Buysse, C.F. Reynolds, T.H. Monk, S.R. Berman, and D.J. Kupfer The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research Psychiatry Research 28 1989 193 213
3. D.J. Buysse, C.F. Reynolds, T.H. Monk, C.C. Hoch, A.L. Yeager, and D.J. Kupfer Quantification of subjective sleep quality in healthy elderly men and women using the Pittsburgh Sleep Quality Index Sleep 14 1989 331 338
4. J.R. Calabrese, J.D. Guelfi, and C. Perdrizet-Chevallier Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data Bipolar Disorder 9 2007 628 635
5. Carlson, B.X.; Ketter, T.A.; Sun, W.; Timko, K.; McQuade, R.D.; Sanchez, R.; Vester-Blokland, E.; Marcus, R.; 2012. Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392). Bipolar Disorders 14, 41-53.
6. K.N. Chengappa, R. Baker, L. Shao, L. Yatham, M. Tohen, S. Gershon, and D. Kupfer Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania Bipolar Disorders 5 2003 1 5
7. M.E. Dokucu, L. Yu, and P.H. Taghert Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila Neuropsychopharmacology 30 2005 2216 2224
8. M.L. Dubocovich, M.A. Rivera-Bermudez, M.J. Gerdin, and M.I. Masana Molecular pharmacology, regulation and function of mammalian melatonin receptors Frontiers in Bioscience 8 2003 1093 1108
9. A. Gentilli, D.K. Weiner, M. Kuchhibhatla, and J.D. Edinger Test-retest reliability of the Pittsburgh Sleep Quality Index in nursing home residents (letter) Journal of the American Geriatrics Society 43 1995 1317 1318
10. P. Gorwood, E. Weiller, O. Lemming, and C. Katona Escitalopram prevents relapse in older patients with major depressive disorder Journal of the American Geriatrics Society 15 2007 581 593
11. A.G. Harvey Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony and regulation American Journal of Psychiatry 165 2008 820 829
12. M. Hyman Rapaport, A. Bose, and H. Zheng Escitalopram continuation treatment prevents relapse of depressive episodes Journal of Clinical Psychiatry 65 2004 44 49
13. International Conference on Harmonisation, 1997. Guideline for Good Clinical Practice. Available at: 〈http://www.ich.org/〉, [accessed 4 November 2011].
14. A. Jackson, J. Cavangh, and J. Scott A systematic review of manic and depressive prodromes Journal of Affective Disorders 74 2003 209 217
15. S.H. Jones, D.J. Hare, and K. Evershed Actigraphic assessment of circadian activity and sleep patterns in bipolar disorder Bipolar Disorder 7 2005 176 186
16. S. Kasper, H. de-Swart, and H.F. Andersen Escitalopram in the treatment of depressed elderly patients American Journal of Geriatric Psychiatry 13 2005 884 891
17. T.A. Ketter, M. Jones, and B. Paulsson Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania Journal of Affective Disorders 100 2007 S45 S53
18. K. Kora, M. Saylan, C. Akkaya, N. Karamustafalioglu, N. Tomruk, A. Yasan, and T. Oral Predictive factors for time to remission and recurrence in patients treated for acute mania: Health outcomes of manic episodes (HOME) study Primary Care Companion to the Journal of Clinical Psychiatry 10 2008 114 119
19. C. Liu, D.R. Weaver, X. Jin, L.P. Shearman, R.L. Pieschl, V.K. Gribkoff, and S.M. Reppert Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock Neuron 19 1997 91 102
20. R. Marcus, A. Khan, L. Rollin, B. Morris, K. Timko, W. Carson, and R. Sanchez Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study Bipolar Disorders 13 2011 133 144
21. C.A. McClung Circadian genes, rhythms, and the biology of mood disorders Pharmacology & Therapeutics 114 2007 222 232
22. S.L. McElroy, E.L. Winstanley, B. Martens, N.C. Patel, N. Mori, D. Moeller, J. McCoy, and P.E. Keck A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance International Clinical Psychopharmacology 26 2011 48 53
23. R.S. McIntyre, D.A. Mancini, J. Srinivasan, S. McCann, J.Z. Konarski, and S.H. Kennedy The antidepressant effects of risperidone and olanzapine in bipolar disorder. Can Journal of Clinical Pharmacology 11 2004 e218 226
24. K.R. Merikangas, H.S. Akiskal, J. Angst, P.E. Greenberg, R.M.A. Hirschfield, M. Petukhova, and R.C. Kessler Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication Archives of General Psychiatry 64 2007 543 552
25. S.A. Montgomery, and M.A. Åsberg A new depression scale designed to be sensitive to change British Journal of Psychiatry 134 1979 382 389
26. G.S. Sachs, J.M. Dupuy, and C.W. Wittman The pharmacologic treatment of bipolar disorder Journal of Clinical Psychiatry 72 2011 704 715
27. SAS Institute Inc, 2004. SAS Version 9.1. Cary, NC.
28. SPSS Inc.; 2009 PASW Version 18, Chicago, IL.
29. M. Tohen, T.G. Jacobs, S.L. Grundy, S.L. McElroy, M.C. Banov, P.G. Janicak, T. Sanger, R. Risser, F. Zhang, V. Toma, J. Francis, G.D. Tollefson, and A. Breier Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study Archives of General Psychiatry 57 2000 841 849
30. R.C. Young, J.T. Biggs, V.E. Ziegler, and D.A. Meyer A rating scale for mania: reliability, validity and sensitivity British Journal of Psychiatry 133 1978 429 435
31. Young, R.C.; Biggs, J.T.; Ziegler, V.E.; Meyer, D.A.; 2000. Young Mania Rating Scale (YMRS). In: American Psychiatric Association, 2000. Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association, pp. 540-554.